The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL https://t.co/sv1q6L5YCn
— Marisa Peer (@PeerMarisa) September 3, 2018
from Twitter https://twitter.com/PeerMarisa
September 02, 2018 at 05:08PM
Sunday, September 2, 2018
The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL https://t.co/sv1q6L5YCn
from Twitter https://twitter.com/PeerMarisa
September 02, 2018 at 05:08PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment